P-246

N/A

Report date: 2023/05/22 10:17:32

Base Information

Drug NameP-246
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A